Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15278 ↗At a glance
Leserbrief in Clinical Transplantation, 2024. Written by Jessica Hedvat and 4 co-authors. Institution: Department of Pharmacy, NewYork-Presbyterian Hospital, New York City, New York, USA. Major MEDLINE topics: Tacrolimus, Organ Transplantation, Nitriles, Pyridines. 5 references.
Abstract (original language)
Ebda abstract disponibbli.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Pharmacy, NewYork-Presbyterian Hospital, New York City, New York, USA.
- Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York City, New York, USA.
ORCID profiles: Jessica Hedvat, Nicholas W Lange, Marcus R Pereira, David M Salerno
Cite
APA
Hedvat, J., Lange, N. W., Scheffert, J. L., Pereira, M. R., & Salerno, D. M. (2024). Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.15278
Vancouver
Hedvat J, Lange NW, Scheffert JL, Pereira MR, Salerno DM. Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients. Clinical Transplantation. 2024. doi:10.1111/ctr.15278
BibTeX
@article{Hedvat2024,
author = {Hedvat, Jessica and Lange, Nicholas W and Scheffert, Jenna L and Pereira, Marcus R and Salerno, David M},
title = {Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15278}
}
EUVIMED